Merck reports positive early data for its experimental COVID-19 pill

Merck reports positive early data for its experimental COVID-19 pill

Submitted by admin on March 8, 2021 - 9:30pm
Source: 
Beckers Hospital Review
News Tags: 
Merck
Ridgeback Biotherapeutics
COVID-19
clinical trials
Headline: 
Merck reports positive early data for its experimental COVID-19 pill
snippet: 

The experimental COVID-19 treatment developed by Merck and Ridgeback Biotherapeutics eliminated the novel coronavirus in clinical trial participants with symptomatic COVID-19 after five days of treatment, the drugmakers announced March 6.

Do Not Allow Advertisers to Use My Personal information